KN046
KN046-204
Phase 2 small_molecule completed
Quick answer
KN046 for Esophageal Squamous Cell Carcinoma is a Phase 2 program (small_molecule) at Jiangsu Alphamab Biopharmaceuticals Co., Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Indication
- Esophageal Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed